Silberstein SD, Diener HC, Dodick DW, Sommer K, et al. Sustained benefits of onabotulinumtoxinA treatment in chronic migraine: An analysis of the pooled Phase 3 REsearch Evaluating Migraine Prophylaxis Therapy (PREEMPT) randomized controlled trials. Headache 2024;64:838-848.
PMID: 38982666